Clinical Trial Update: Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial assessing VAC BNO 1095 shows dose-dependent effects on cyclic mastodynia and premenstrual syndrome. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cyclic Mastodynia
• Premenstrual Syndrome

Drugs mentioned

• VAC BNO 1095

Snippet

Sponsor: Bionorica SE | Conditions: Cyclic Mastodynia, Premenstrual Syndrome | Phase 3 | Status: COMPLETED